Role of reactive oxygen formation in the cyclosporin-A-mediated impairment of renal functions.
Wolf
A
A
Sandoz Pharma Ltd., Basle, Switzerland.
Clemann
N
N
Frieauff
W
W
Ryffel
B
B
Cordier
A
A
D000818:Animals; D002374:Catalase / Q000494:pharmacology; D002478:Cells, Cultured; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000633:toxicity*; D006384:Hemagglutination; D007668:Kidney / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism; D007678:Kidney Glomerulus / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D017382:Reactive Oxygen Species / Q000378:metabolism*; D012016:Reference Values; D013482:Superoxide Dismutase / Q000494:pharmacology; D013997:Time Factors
D017382:Reactive Oxygen Species; D016572:Cyclosporine; D003404:Creatinine; D002374:Catalase; D013482:Superoxide Dismutase